Characterization of the gila monster (Heloderma suspectum suspectum) venom proteome.
Level 5 - mechanism / opinion, no new human data
Bench laboratory research characterizing animal venom proteome (non-clinical study).
PubMed 25603280 · doi:10.1016/j.jprot.2015.01.004
What was done
The venom proteome of the Gila monster (Heloderma suspectum suspectum) was characterized using two-dimensional gel electrophoresis (2D-PAGE) combined with tandem mass spectrometry (MS/MS)-based de novo peptide sequencing and homology-based sequence identification. Fifty-eight major protein spots were selected from the gels for analytical identification.
What was found
Analysis of the 58 selected spots yielded 39 distinct proteins, 19 of which had not been previously identified in helodermatid venom. Major constituents identified were kallikrein-like serine proteinases (EC 3.4.21) and type III phospholipase A2 enzymes (EC 3.1.1.4). In addition, a neuroendocrine convertase 1 homolog was detected, suggesting that bioactive exendin peptide toxins are secreted as proforms and activated by extracellular proteolytic cleavage rather than intracellularly.
Why it matters
This study provides the first global proteomic catalog of Gila monster venom without relying on a pre-existing sequenced genome. Mapping these constituents expands knowledge of reptile toxin evolution and provides reference data for potential therapeutic candidates.
Limits
The abstract does not report the sample size of lizards or venom samples analyzed. Identification was restricted to 58 prominent 2D-gel spots, omitting low-abundance proteins. Functional biological assays and pharmacological mechanisms of the newly identified proteins were not measured.
Cited by
- supports Exendin-4 was isolated and identified from the venom of the Gila monster.